Skip to search formSkip to main contentSkip to account menu

motexafin gadolinium

Known as: Gd (III) Texaphryin, Gadolinium Texaphyrin, Gd(III) texaphyrin 
A synthetic metallotexaphyrin with radiosensitizing and chemosensitizing properties. Motexafin gadolinium accumulates in tumor cells preferentially… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BackgroundPhotodynamic therapy (PDT) is photo-treatment of malignant or benign diseases using photosensitizing agents, light, and… 
Review
2012
Review
2010
Review
2010
Magnetism in medicine has had a long and interesting history. In the 10 th century A.D., Egyptian physician and philosopher… 
Highly Cited
2006
Highly Cited
2006
Motexafin gadolinium (MGd) is a chemotherapeutic drug that selectively targets tumor cells and mediates redox reactions… 
Review
2004
Review
2004
PURPOSE To report the neurocognitive findings in a phase III randomized trial evaluating survival and neurologic and… 
Review
2004
Review
2004
  • M. Renschler
  • European Journal of Cancer
  • 2004
  • Corpus ID: 13587006
Review
2003
Review
2003
PURPOSE This phase III randomized trial evaluated survival as well as neurologic and neurocognitive function in patients with… 
Highly Cited
1999
Highly Cited
1999
Highly Cited
1996
Highly Cited
1996
Gadolinium(III) texaphyrin (Gd-tex2+) is representative of a new class of radiation sensitizers detectable by magnetic resonance… 
Highly Cited
1996
Highly Cited
1996
Lutetium texaphyrin, PCI‐0123, is a pure, water‐soluble photosensitizer with a large broad absorption band centered at 732 nm…